ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET FORECAST 2023-2032

The Asia-Pacific retinal imaging devices market growth assessment includes the analysis of India, China, Vietnam, South Korea, Thailand, Indonesia, Japan, Australia & New Zealand, and Rest of Asia-Pacific. As per findings from the Glaucoma Research Foundation, individuals of East Asian descent exhibit the highest incidence of blindness attributed to one of the two most prevalent types of glaucoma. Among urban Chinese populations, there is a notable disparity in the prevalence of Primary Angle-Closure Glaucoma (PACG) when compared to Primary Open Angle Glaucoma (POAG), with a ratio of 2 to 1. This means that PACG affects twice as many Chinese individuals as open-angle glaucoma does. 

PACG is a more aggressive form of glaucoma and accounts for approximately 90% of all glaucoma-related cases of blindness in China. The growing prevalence of ocular conditions, including diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma, significantly drives the China retinal imaging devices market growth.

Furthermore, as per the 2021 projections by BPS-Statistics Indonesia, Indonesia is anticipated to have a population of 2,982 million elderly individuals, constituting 10.82% of the overall populace. Furthermore, BPS-Statistics Indonesia reports a noteworthy rise in life expectancy, which increased from 70.2 years in 2012 to 73.5 years in 2021. This increase in the geriatric population raises concerns related to eye health, including conditions such as diabetic retinopathy and age-related macular degeneration (AMD).

The Asia-Pacific retinal imaging devices market segmentation includes device type and end use. The end use segment includes ophthalmic center, ambulatory surgery center, hospital, and other end uses.

Ambulatory Surgery Centers (ASCs) have emerged as significant stakeholders in the field of retinal imaging devices, contributing to the advancement of eye care beyond traditional hospital environments. These specialized centers are equipped with state-of-the-art retinal imaging technologies, such as optical coherence tomography (OCT) and fundus cameras, enabling them to conduct efficient and precise assessments of the retina. ASCs leverage retinal imaging devices to streamline the processes of diagnosis, pre-operative evaluations, and post-operative monitoring for various retinal conditions, including macular degeneration, retinal detachment, and diabetic retinopathy.

Some of the leading companies in the Asia-Pacific retinal imaging devices market are TOPCON CORPORATION, NIDEK CO LTD, Kowa Company Ltd, etc.

TOPCON CORPORATION is engaged in the manufacture and design of solutions for a vast range of sectors. The company’s product portfolio includes agricultural solutions, medical imaging systems, construction & surveying equipment, and ophthalmic instruments. It provides diagnostics tools and retinal imaging technologies in ophthalmology to help manage and diagnose eye disorders. The company’s solutions are used throughout Asia, Europe, North America, etc., with headquarters in Tokyo, Japan. 

One of its key products, Topcon Triton Swept Source OCT, is used for high-resolution, fast imaging of the choroid and the retina.